A Prospective, Randomized, Controlled, Multicenter Study of Naftopidil for Treatment of Male Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia: 75 mg Once Daily in the Evening Compared to 25 mg Thrice Daily

2010 ◽  
Vol 85 (1) ◽  
pp. 80-87 ◽  
Author(s):  
Shinji Tsuritani ◽  
Tetsuo Nozaki ◽  
Akiou Okumura ◽  
Hitomi Kimura ◽  
Taizo Kazama
Sign in / Sign up

Export Citation Format

Share Document